Address
Hemmelrather Weg 201
Leverkusen, 51377
Germany
Phone
49 214 87 63 2 0
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
91
First IPO Date
October 31, 2006
| Name | Title | Pay | Year Born |
| Pilar de la Huerta | Chief Financial Officer & Member of Executive Board | 369,000 | 1969 |
| Ludwig Lutter | Member of the Executive Board | 435,646 | 1967 |
| Matthias Naumann | Head of Sales & Marketing - Europe | 0 | N/A |
| Montserrat Foguet | Managing Director of Biofrontera UK Ltd. | 0 | N/A |
| Alexander Richardson | Head of UK Sales Team | 0 | N/A |
Based in Leverkusen, Germany, Biofrontera AG is a biopharmaceutical firm established in 1997, dedicated to the innovation, development, and marketing of skincare therapies. Its primary offerings include Ameluz, paired with the BF-RhodoLED lamp, engineered to address mild to moderate actinic keratoses on the face and scalp, field cancerization, and aggressive squamous cell carcinoma. The company also provides RhodoLED XL for managing multiple dispersed lesions, Belixos, an advanced cosmetic line for sensitive and irritated skin, and Xepi, a solution targeting antibiotic-resistant bacterial infections. Biofrontera's products are distributed mainly across the United States, Europe, and Israel, and its operations are strengthened by a collaboration agreement with Maruho Co., Ltd.